Cannabis Company Forms Partnership to Develop Pharmaceuticals

Source: Streetwise Reports   10/06/2017 Analyst Russell Stanley with Echelon Wealth Partners explained the significance of the recent licensing agreement signed by this Canadian medical marijuana producer and distributor. In an Oct. . . . → Read More: Cannabis Company Forms Partnership to Develop Pharmaceuticals Similar Articles: Medical Cannabis Innovator Set to Go Public Canadian Medical Cannabis Provider Expanding into US Market Through RTO RXi Pharmaceuticals Expands Collaboration with Norwegian Cancer Firm; Gears Up for 2017 Milestones